KIDRON NADAV (President and CEO) reported 1 transaction at ORAMED PHARMACEUTICALS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/16/2026ACC: 0001213900-26-028291
DirectorOfficer10% Owner· President and CEO
Since Jul 2018
-100K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
100K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−100K
Price / share
—
Trade value
—
% of position
3.0%
3/12/2026
3.36M→3.26M
Total
Net shares
−100K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/12/2026 | G · Gift | −100K | — | — | 3.0% | 3.36M | 3.26M |
| Total | −100K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported